LUNG
USDPulmonx Corporation Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$1.790
उच्च
$1.790
कम
$1.660
मात्रा
0.89M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
69.4M
उद्योग
चिकित्सा उपकरण
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
2.37M
एक्सचेंज
NMS
मुद्रा
USD
52-सप्ताह रेंज
AI विश्लेषण रिपोर्ट
अंतिम अपडेट: 31 अक्टू॰ 2025LUNG (Pulmonx Corporation) Market Analysis: Undervalued MedTech with Mixed Signals
Quick Overview
Pulmonx (LUNG) trades at $2.03 as of October 31, 2025, with a negative P/E ratio (-1.27) and small market cap ($82.6M). Recent analyst upgrades and a management shakeup dominate headlines, while technical indicators show caution. Fundamental scores suggest potential value, but debt and weak equity returns weigh down long-term confidence.
Key News Sentiment
- Analyst Optimism Amid Lower Targets
- Lake Street and D. Boral Capital kept "Buy" ratings but slashed price targets (from $8 → $4 and $16 → $14).
- Why it matters: Analysts see long
संबंधित समाचार
Lake Street Maintains Buy on Pulmonx, Lowers Price Target to $4
Lake Street analyst Frank Takkinen maintains Pulmonx with a Buy and lowers the price target from $8 to $4.
D. Boral Capital Maintains Buy on Pulmonx, Lowers Price Target to $14
D. Boral Capital analyst Jason Kolbert maintains Pulmonx with a Buy and lowers the price target from $16 to $14.
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Officer, appointed
AI भविष्यवाणीBeta
AI सिफारिश
पर अपडेट किया गया: 4 नव॰ 2025, 06:55 pm
61.4% आत्मविश्वास
जोखिम और ट्रेडिंग
प्रवेश बिंदु
$1.81
लाभ लें
$2.06
स्टॉप लॉस
$1.66
मुख्य कारक
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।